NSW’s overall performance
Improving research ethics and governance approval timelines, particularly for clinical trials is a key priority for NSW.
Table 1. Performance of NSW HREC and Sites in COVID-19 research start-up times across all risk categories
- Ethics applications are approved < 2 weeks
- Site applications are approved < 1 week
- Average study start-up time is < 6 weeks (end-to-end)
Figure 1. (A) Heatmap illustrating the distribution of approved COVID-19 research across NSW local health districts. (B) Breakdown of COVID-19 applications by research category. (C) Schematic representation of the breakdown of approved COVID-19 research by ethics review pathway and corresponding ethics review times (clock-on).
Figure 2. (A) The distribution of approved COVID-19 research sites across NSW LHDs. (B) Breakdown of COVID-19 site applications by research category. (C) Schematic representation of the breakdown of approved COVID-19 site-specific application (SSA) by ethics review pathway and corresponding SSA review times (clock-on).
Updated 1 year ago